Skip to main content
logo
Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.8190
+0.0384 (4.92%)
Apr 7, 2026, 4:00 PM EDT - Market closed

Evogene Revenue

In the year 2025, Evogene had annual revenue of $3.85M, down -30.91%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$3.85M
Revenue Growth
-30.91%
P/S Ratio
2.11
Revenue / Employee
$32,932
Employees
117
Market Cap
8.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.85M-1.72M-30.91%
Dec 31, 20245.58M2.60M87.02%
Dec 31, 20232.98M1.31M78.03%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bolt Biotherapeutics7.70M
CollPlant Biotechnologies2.37M
Aprea Therapeutics285.76K
Kiora Pharmaceuticals20.00K
Creative Medical Technology Holdings6.00K
Revenue Rankings

EVGN News

More News